Based on our previous data and reports from others suggesting that the p110 CUX1 variant induces tumor-promoting signaling pathways, we aimed to establish a conditional mouse model expressing p110 CUX1 to investigate its effects on PDAC formation in context with KRAS. Here, KRAS is linked to neoplasm.